Physician profile
Kate M Murphy
NPI 1518391184
$653.49
in general payments reported to CMS, 2019-2025
12 companies · $20.20 in 2025
The $20.20 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $55.52 · 2023: $63.54 · 2024: $167 · 2025: $20.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $175.81 | 2021-2023 | Otezla |
| Novo Nordisk INC | $157.22 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $66.79 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $48.91 | 2024 | Airsupra |
| Glaxosmithkline, LLC. | $42.37 | 2022-2025 | Trelegy Ellipta |
| Amarin Pharma, INC. | $38.24 | 2021 | |
| Lilly USA, LLC | $26.28 | 2021-2024 | Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $23.62 | 2024 | Spravato |
| Abbvie INC. | $22.84 | 2024 | |
| Genentech USA, INC. | $19.53 | 2021 | |
| Merck Sharp & Dohme LLC | $16.30 | 2021 | |
| Exact Sciences Corporation | $15.58 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.